854 related articles for article (PubMed ID: 24798552)
1. Defining dysbiosis and its influence on host immunity and disease.
Petersen C; Round JL
Cell Microbiol; 2014 Jul; 16(7):1024-33. PubMed ID: 24798552
[TBL] [Abstract][Full Text] [Related]
2. Richness and diversity of mammalian fungal communities shape innate and adaptive immunity in health and disease.
Rizzetto L; De Filippo C; Cavalieri D
Eur J Immunol; 2014 Nov; 44(11):3166-81. PubMed ID: 25257052
[TBL] [Abstract][Full Text] [Related]
3. Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch's postulates.
Zhao H; Zhang W; Cheng D; You L; Huang Y; Lu Y
Front Med (Lausanne); 2022; 9():1023896. PubMed ID: 36438062
[TBL] [Abstract][Full Text] [Related]
4. Role of microbiota and innate immunity in recurrent Clostridium difficile infection.
Bibbò S; Lopetuso LR; Ianiro G; Di Rienzo T; Gasbarrini A; Cammarota G
J Immunol Res; 2014; 2014():462740. PubMed ID: 24995345
[TBL] [Abstract][Full Text] [Related]
5. Cancer-promoting effects of microbial dysbiosis.
Sheflin AM; Whitney AK; Weir TL
Curr Oncol Rep; 2014 Oct; 16(10):406. PubMed ID: 25123079
[TBL] [Abstract][Full Text] [Related]
6. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
7. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.
Rodríguez C; Romero E; Garrido-Sanchez L; Alcaín-Martínez G; Andrade RJ; Taminiau B; Daube G; García-Fuentes E
Gut Microbes; 2020 Nov; 12(1):1725220. PubMed ID: 32129694
[TBL] [Abstract][Full Text] [Related]
8. Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis.
Calvo-Barreiro L; Eixarch H; Montalban X; Espejo C
Autoimmun Rev; 2018 Feb; 17(2):165-174. PubMed ID: 29191793
[TBL] [Abstract][Full Text] [Related]
9. Microbiota-Nourishing Immunity: A Guide to Understanding Our Microbial Self.
Litvak Y; Bäumler AJ
Immunity; 2019 Aug; 51(2):214-224. PubMed ID: 31433969
[TBL] [Abstract][Full Text] [Related]
10. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
11. The human microbiome: opportunities and challenges for clinical care.
Rogers GB
Intern Med J; 2015 Sep; 45(9):889-98. PubMed ID: 25443179
[TBL] [Abstract][Full Text] [Related]
12. Drosophila as a model for intestinal dysbiosis and chronic inflammatory diseases.
Lee KA; Lee WJ
Dev Comp Immunol; 2014 Jan; 42(1):102-10. PubMed ID: 23685204
[TBL] [Abstract][Full Text] [Related]
13. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.
Lin L; Zhang J
BMC Immunol; 2017 Jan; 18(1):2. PubMed ID: 28061847
[TBL] [Abstract][Full Text] [Related]
14. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
Yu LC
J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
[TBL] [Abstract][Full Text] [Related]
15. Immune responses to Clostridium difficile infection.
Madan R; Petri WA
Trends Mol Med; 2012 Nov; 18(11):658-66. PubMed ID: 23084763
[TBL] [Abstract][Full Text] [Related]
16. Host-microbiota interplay in mediating immune disorders.
Felix KM; Tahsin S; Wu HJ
Ann N Y Acad Sci; 2018 Apr; 1417(1):57-70. PubMed ID: 28984367
[TBL] [Abstract][Full Text] [Related]
17. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
Raftery AL; Tsantikos E; Harris NL; Hibbs ML
Front Immunol; 2020; 11():2144. PubMed ID: 33042125
[TBL] [Abstract][Full Text] [Related]
18. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.
Peterson CT; Sharma V; Elmén L; Peterson SN
Clin Exp Immunol; 2015 Mar; 179(3):363-77. PubMed ID: 25345825
[TBL] [Abstract][Full Text] [Related]
19. From stool transplants to next-generation microbiota therapeutics.
Petrof EO; Khoruts A
Gastroenterology; 2014 May; 146(6):1573-1582. PubMed ID: 24412527
[TBL] [Abstract][Full Text] [Related]
20. T lymphocytes in the intestinal mucosa: defense and tolerance.
Ma H; Tao W; Zhu S
Cell Mol Immunol; 2019 Mar; 16(3):216-224. PubMed ID: 30787416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
